title: Does activity of anticancer drugs in advanced cancer always translates in effectivity in early-stage high-risk disease?
authors.affiliation: Department of Medical Oncology, Ziekenhuisnetwerk Antwerpen-Middelheim, Antwerp, Belgium. Electronic address: dirk.schrijvers@zna.be.
authors.forename: D L A L
authors.initials: DLAL
authors.lastname: Schrijvers
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic / Q000379:methods*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality; D012107:Research Design; D055752:Small Cell Lung Carcinoma / Q000188:drug therapy / Q000401:mortality
chemical_list: D000970:Antineoplastic Agents; D000068258:Bevacizumab